Casi Pharmaceuticals Inc (CASI)
2.10 -0.06 (-2.78%) 15:59 ET [NASDAQ]
2.05 x 30 2.42 x 4
Realtime by (Cboe BZX)
2.05 x 30 2.42 x 4
Realtime - - (-) -
for Mon, Mar 31st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,132 | 8,049 | 1,081 | 4,886 | 6,312 |
| Marketable Securities | N/A | N/A | N/A | 26 | 54 |
| Receivables | N/A | 669 | 1,933 | 2,750 | 3,287 |
| TOTAL | $15,411 | $8,908 | $3,207 | $7,928 | $9,874 |
| Non-Current Assets | |||||
| PPE Net | 78 | 53 | 25 | 105 | 172 |
| Other Non-Current Assets | 18 | 17 | 4 | 5 | 22 |
| TOTAL | $96 | $70 | $29 | $109 | $193 |
| Total Assets | $15,508 | $8,978 | $3,236 | $8,037 | $10,067 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 758 | 8,555 |
| Accounts payable and accrued liabilities | 403 | 592 | 453 | 1,351 | 1,969 |
| Accrued Expenses | 163 | 151 | 251 | 595 | 745 |
| TOTAL | $565 | $743 | $704 | $2,704 | $11,269 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 724 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $724 |
| Total Liabilities | $565 | $743 | $704 | $2,704 | $11,993 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,704 | 2,702 | 1,224 | 1,153 | 870 |
| Common Shares | 271 | 226 | 122 | 115 | 81 |
| Retained earnings | -399,070 | -393,331 | -378,786 | -374,228 | -366,126 |
| Other shareholders' equity | -34 | -34 | 3,316 | 3,316 | 3,316 |
| TOTAL | $14,942 | $8,235 | $2,532 | $5,333 | $-1,926 |
| Total Liabilities And Equity | $15,508 | $8,978 | $3,236 | $8,037 | $10,067 |